Analyst firms · BofA Securities · SGRY
BofA Securities SGRY price target and rating history
Surgery Partners Inc. (SGRY) · Health Care
BofA Securities rates Surgery Partners Inc. (SGRY) Buy with a $28 price target, as of its latest action on Jul 28, 2025. It has published 4 rating actions on SGRY since June 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $28
- Median target, all firms
- Too few
- Actions on SGRY
- 4
BofA Securities price target on SGRY
Every BofA Securities rating on SGRY
- Jul 28, 2025
- Dec 16, 2024
- Jun 2, 2023
- Jun 15, 2022
Questions about BofA Securities and SGRY
- What is BofA Securities's price target for SGRY?
- BofA Securities's latest stated price target for Surgery Partners Inc. (SGRY) is $28, from its action on Jul 28, 2025.
- What is BofA Securities's rating on SGRY?
- BofA Securities rates SGRY Buy, a bullish rating, as of Jul 28, 2025.
- When did BofA Securities last change its view on SGRY?
- On Jul 28, 2025, BofA Securities resumes coverage at Buy, price target $28.
More SGRY rating histories
All BofA Securities ratingsSGRY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.